Adh1b and Cdh1 Polymorphisms Predict Prognosis in Male Patients with Non-Metastatic Laryngeal Cancer

Daxu Li,Ruizhi Zhang,Tianbo Jin,Na He,Le Ren,Zhe Zhang,Qingna Zhang,Ran Xu,Hong Tao,Guang Zeng,Jing Gao
DOI: https://doi.org/10.18632/oncotarget.12301
2016-01-01
Oncotarget
Abstract:In this study, we assessed the association between single nucleotide polymorphisms (SNPs) in candidate genes and the prognosis of laryngeal cancer (LC) patients. Thirty-seven SNPs in 26 genes were genotyped in 170 male Han Chinese patients with LC. The effects of the candidate genes on the prognosis of LC patients were evaluated using Kaplan-Meier curves and Cox proportional hazards regression models. The GA genotype of rs1229984 (hazard ratio [HR], 0.537; 95% confidence interval [CI], 0.340-0.848; p = 0.008) in alcohol dehydrogenase 1B (ADH1B), and the AA genotype of rs9929218 (HR, 6.074; 95% CI, 1.426-25.870; p = 0.015) in CDH1 were associated with overall survival. Our data suggest that polymorphisms in ADH1B and CDH1 may be prognostic indicators in LC.
What problem does this paper attempt to address?